MedPath

Analysis of blood NAD+ pathway metabolites in healthy subjects

Not Applicable
Conditions
/A
Registration Number
JPRN-UMIN000041232
Lead Sponsor
Hamamatsu University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
5
Inclusion Criteria

Not provided

Exclusion Criteria

1. Those who take supplements containing vitamin B3 and wish to continue during the trial. 2. Those who are potentially pregnant. 3. Those who are under lactation. 4. Those who are under treatment. 5. Those judged by doctors or researchers to be inappropriate to participation in research.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath